Schedule Dispatches

This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.

The full Update is available as a PDF(external link)

The changes will be published in the online Schedule around the 23^rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz

November 2024

New Listings

• Acetylcysteine (DBL Acetylcysteine) inj 200 mg per ml, 10 ml ampoule (p’code 2260794)
• Amoxicillin with clavulanic acid (Amoxiclav Devatis Forte) grans for oral liq amoxicillin 50 mg with clavulanic acid 12.5 mg per ml, 100 ml OP – up to 200 ml available on a PSO (p’code 2684748)
• Bendamustine hydrochloride (Bendamustine Sandoz) inj 25 mg (p’code 2691434) and 100 mg vial (p’code 2691442) – PCT only – Specialist – Special Authority
• Fosfomycin (UroFos) powder for oral solution, 3 g sachet – Special Authority – Retail pharmacy (p’code 2538210)
• Hyoscine butylbromide (Hyoscine Butylbromide (Adiramedica)) tab 10 mg (p’code 2687224)
• Ibuprofen (Ibuprofen SR BNM) tab long-acting 800 mg (p’code 2690276)
• Itraconazole (Kent) oral liq 10 mg per ml, 150 ml OP – Special Authority – Retail Pharmacy and s29 (p’code 2693364)
• Naloxone hydrochloride (DBL Naloxone Hydrochloride) inj 400 mcg per ml, 1 ml ampoule – up to 10 inj available on a PSO and only on a PSO (p’code 788457)
• Niraparib (Zejula) tab 100 mg – Special Authority – Retail pharmacy and wastage claimable (p’code 2690683)
• Oestradiol (Estrogel) gel (transdermal) 0.06% (750 mcg/actuation), 80 g OP (p’code 2656191)
• Oil in water emulsion (Fatty Emulsion Cream (Evara)) crm, 500 g (p’code 2491311)
• Pemetrexed (Pemetrexed-AFT) inj 100 mg vial (p’code 2693917) and 500 mg vial (p’code 2693925) – PCT only - Specialist
• Teriflunomide (Teriflunomide Sandoz) tab 14 mg – Special Authority – Retail pharmacy and wastage claimable (p’code 2691426)

Changes to restrictions, chemical names and presentations

• Adalimumab (Amgevita) inj 20 mg per 0.4 ml prefilled syringe and inj 40 mg per 0.8 ml prefilled pen and prefilled syringe – amended Special Authority criteria
• Aripiprazole (Abilify Maintena and Abilify Maintena S29) inj 300 mg and 400 mg vial – amended Special Authority criteria
• Atorvastatin (Lorstat) tab 10 mg, 20 mg and 40 mg – reinstate stat dispensing
• Bendamustine hydrochloride inj 25 mg and 100 mg vial (Ribomustin and Bendamustine Sandoz) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
• Cetuximab inj 5 mg per ml, 20 ml vial and 100 ml vial (Erbitux) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
• Etanercept (Enbrel) inj 25 mg, inj 25 mg autoinjector and inj 50 mg autoinjector and prefilled syringe – amended Special Authority criteria
• Ezetimibe (Ezemibe Viatris and Ezetimibe Sandoz) tab 10 mg – removal of stat dispensing
• Infliximab inj 100 mg (Remicade) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
• Insulin pump infusion set (steel cannula, straight insertion) (mylife Orbit micro) 5.5 mm steel cannula; straight insertion; 45 cm line × 10 with 10 needles, 1 OP and 5.5 mm steel needle; straight insertion; 60 cm line × 10 with 10 needles, 1 OP – removal of stat dispensing
• Iron (as ferric carboxymaltose) (Ferinject) inj 50 mg per ml, 10 ml vial – amended Special Authority criteria
• Nivolumab inj 10 mg per ml, 4 ml and 10 ml vial (Opdivo) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
• Norethisterone (Norethinderone – CDC) tab 350 mcg – removal of s29 and wastage claimable
• Oestradiol (Lyllana) patch 25 mcg, 50 mcg, 75 mcg and 100 mcg per day – removal of s29 and wastage claimable
• Paliperidone (Invega Sustenna) inj 25 mg, 50 mg, 75 mg, 100 mg and 150 mg syringe – amended Special Authority criteria
• Pemetrexed inj 100 mg and 500 mg vial (Juno Pemetrexed and Pemetrexed-AFT) and inj 1 mg for ECP (Baxter) – removal of Special Authority criteria
• Phenobarbitone (Noumed Phenobarbitone) tab 15 mg – removal of brand switch fee
• Pregabalin cap 25 mg, 150 mg and 300 mg (Pregabalin Pfizer), cap 25 mg (Milpharm) and cap 150 mg (Lyrica) – reinstate stat dispensing
• Risperidone (Risperdal Consta) inj 25 mg, 37.5 mg and 50 mg vial – amended Special Authority criteria
• Secukinumab (Cosentyx) inj 150 mg per ml, 1 ml prefilled syringe – amended Special Authority criteria
• Tocilizumab inj 20 mg per ml, 4 ml, 10 ml and 20 ml vial (Actemra) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria

Increased subsidy

Chemical	Presentation	Fully subsidised brands
Ibuprofen	Oral liq 20 mg per ml, 200 ml	Ethics

Decreased subsidy        

Chemical	Presentation	Fully subsidised brands
Pemetrexed	Inj 1 mg for ECP	Baxter